US Stock MarketDetailed Quotes

Biogen (BIIB)

Watchlist
  • 187.060
  • -2.220-1.17%
Close May 1 16:00 ET
  • 187.170
  • +0.110+0.06%
Post 20:01 ET
27.62BMarket Cap20.11P/E (TTM)

Biogen (BIIB) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
TYSABRI441.5M17.82%
Revenue from anti-CD20 therapeutic programs419.1M16.91%
SPINRAZA374M15.09%
Other271.8M10.97%
Contract manufacturing, royalty and other revenue246.9M9.96%
VUMERITY179M7.22%
AVONEX163.2M6.59%
SKYCLARYS150.7M6.08%
BENEPALI122.1M4.93%
TECFIDERA109.5M4.42%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
U.S.5.74B58.01%
Europe1.88B19.05%
Germany853M8.62%
Asia726.5M7.35%
Other511.2M5.17%
Alzheimer's collaboration revenue177.7M1.80%
View all
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More